Jason Comerford

Chartwell in its $345 million trust unit offering

On June 27, 2024, Chartwell Retirement Residences (Chartwell) announced the closing of its previously announced public offering of 28,290,000 trust units at a price of $12.20 per unit for total gross proceeds of approximately $345 million. The financing was completed on a bought deal basis through...

Lead Office: Toronto Date Announced: Jun 27, 2024 Value: $345 million

ADENTRA Inc. in its Bought Deal Public Offering of Common Shares

On June 12, 2024, ADENTRA Inc. completed its bought deal public offering of 2,582,900 common shares for aggregate gross proceeds of $100,087,375. The offering was conducted by a syndicate of underwriters with National Bank Inc. and Cormark Securities Inc. acting as co-bookrunners. ADENTRA is...

Lead Office: Vancouver Date Announced: Jun 12, 2024 Value: Approximately $100.09 million

Tantalus Systems Holding Inc. in its closing of $10 million bought deal offering

On May 23, 2024, Tantalus Systems Holding Inc. closed a bought deal offering of its common shares pursuant to the listed issuer financing exemption and a concurrent private placement for total gross proceeds of $10 million. For this offering, Cormark Securities Inc. and Canaccord Genuity Corp....

Lead Office: Vancouver Date Announced: May 23, 2024 Value: $10 million

The Syndicate of agents in TELUS Corporation’s $2 billion three-tranche note offering

On September 13, 2022, TELUS Corporation closed its $2 billion offering of senior unsecured notes in three series, the first with a 10-year maturity, the second with a 30-year maturity and the third with a 7-year maturity. The notes were offered through a syndicate of agents led by CIBC Capital...

Lead Office: Toronto Date Closed: September 13, 2022 Value: $2 billion

The Underwriters in connection with TELUS Corporation’s US$900 million Sustainability-Linked Bond offering

On February 23, 2022, TELUS Corporation announced its US$900 million offering of senior unsecured Sustainability-Linked notes. The notes are offered through a syndicate of underwriters led by J.P Morgan Securities LLC, TD Securities (USA) LLC, and Wells Fargo Securities, LLC. The notes are...

Lead Office: Toronto Date Closed: February 23, 2022 Value: US$900 million

Tantalus Systems in its acquisition of Congruitive

On February 1, 2022, Tantalus Systems Holdings acquired DLC Systems, Inc. d/b/a Congruitive for a purchase price that includes US$8 million of closing consideration and up to US$5 million through a two-year earn-out. The acquisition of Congruitive will provide Tantalus Systems the opportunity...

Lead Office: Vancouver Date Closed: February 1, 2022 Value: US$8 million

Hardwoods Distribution Inc. in its $100.6 million offering

On December 7, Hardwoods Distribution Inc. completed its $100.6 million public offering of common shares, including the exercise in full of an over-allotment option granted to the underwriters. The offering was led by Cormark Securities Inc. and National Bank Financial Inc., acting as...

Lead Office: Vancouver Date Closed: December 7, 2021 Value: $100.6 million

Q4 Inc. in its IPO on the TSX

On October 29, 2021, Q4 Inc. completed its initial public offering of common shares on the Toronto Stock Exchange. Pursuant to the offering, Q4 raised gross proceeds of approximately $100 million. Q4 plans to use the proceeds to repay debts related to its credit facilities and pursue its growth...

Lead Office: Toronto Date Closed: October 29, 2021 Value: $100 million

Clio in its acquisition of Lawyaw

On September 8, 2021, Clio announced its acquisition of Lawyaw, a San Francisco-based company focused on creating digital workflows for legal documents. Lawyaw has a long-standing data integration with Clio, and was the first document automation software to be included in Clio’s app...

Lead Office: Vancouver Date Closed: September 8, 2021 Value: -

Acasti in its definitive agreement to acquire Grace Therapeutics

On May 7, 2021, Acasti Pharma announced the entering into of a definitive agreement to acquire Grace Therapeutics, a biopharmaceutical company that develops innovative drug delivery technologies for rare and orphan diseases. Upon completion of the acquisition, Acasti will acquire...

Lead Office: Montreal Date Closed: August 27, 2021 Value: -